Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Scribe Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
Scribe Therapeutics, Inc. has 2 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either Scribe Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“On November 7, 2022, we entered into a development and option agreement, or the Acuitas Development and Option Agreement, with Acuitas Therapeutics, Inc., as supplemented and amended from time to time, the Acuitas Agreement”
FILINGS-1/A0001193125-26-308330cik 0001853921
“On September 25, 2018, we entered into an exclusive license agreement with the Regents of the University of California, or the Regents”
FILINGS-1/A0001193125-26-308330cik 0001853921
“We have funded our operations to date primarily from proceeds received under collaboration and license agreements with Sanofi, Lilly and Biogen”
FILINGS-1/A0001193125-26-308330cik 0001853921
“Sanofi has the right to terminate the 2023 Sanofi License Agreement with respect to a licensed product, licensed target or in its entirety for convenience”
FILINGS-1/A0001193125-26-308330cik 0001853921
“On May 11, 2023, we entered into a license and collaboration agreement, or the Lilly License Agreement, with Prevail Therapeutics, Inc., a wholly-owned subsidiary of Eli Lilly and Company, for research and development collaborations and granting to Prevail exclusive license rights under patents and technology for certain products”
FILINGS-1/A0001193125-26-308330cik 0001853921
Watchlist prices, news filtered to it, and its next report on your desk.
SCTX (Scribe Therapeutics, Inc.) has 2 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: SNY −2.03%, in industrials & materials.